Table 1. Study components, timeline, and sample size per study activity.
Study Component | Timeline | Sample Size | Intervention/Activity |
---|---|---|---|
Part A: Vaccination | 2018 Dec-2019 Feb | All eligible 8,000~9,000* schoolgirls (<15 years old) in Grade 8 per province | Udon Thani: single-dose HPV vaccine regimen Buri Ram: two-dose HPV vaccine regimen 6 months apart |
N = 1,500 for SBQ | |||
N = 200 (pre-vaccine serology) | |||
Part B: Baseline CSS | 2018 Dec-2019 Feb | G10/V1: N = 2,600 schoolgirls per province | SBQ and HPV urine prevalence |
G12/V3: N = 2,000 schoolgirls per province | |||
Part C: Year 2 CSS | 2020 Dec-2021 Feb | G10/V1: N = 2,600 schoolgirls per province | SBQ and HPV urine prevalence |
N = 200 (serology) | |||
Part D: Year 4 CSS | 2022 Dec-2023 Feb | G12/V3: N = 2,000 schoolgirls per province | SBQ and HPV urine prevalence |
N = 200 (serology) |
*Approximate number of Grade 8 schoolgirls that will be eligible and offered vaccination